GLP-1 medications like semaglutide and tirzepatide have become the most requested weight-loss treatments in the country. Your patients are already asking about them. The question for a chiropractic practice isn't whether there's demand — it's how to meet that demand compliantly, without stepping outside your scope of practice or building a medical clinic from scratch.
This page explains how chiropractors can offer a GLP-1 weight loss program, why it fits naturally alongside chiropractic care, and how the turnkey model removes the legal and operational barriers that stop most practices from getting started.
Why GLP-1 weight loss fits a chiropractic practice
Excess weight is one of the biggest drivers of the musculoskeletal problems you already treat — low back pain, joint loading, disc compression, and slow recovery from adjustments. When a patient loses weight and lowers systemic inflammation, your hands-on work holds longer and outcomes improve. A GLP-1 program isn't a departure from chiropractic care; it's a clinical complement to it.
It's also a business fit. GLP-1 programs are typically delivered as monthly, cash-pay memberships. That means predictable recurring revenue layered on top of your per-visit income — without insurance billing, and without the overhead of new clinical staff.
Can chiropractors prescribe semaglutide or tirzepatide?
In nearly every state, chiropractors cannot write prescriptions for GLP-1 medications. That's exactly why the turnkey, partner-based model exists. Instead of prescribing yourself, you connect your patient to a network of independent, licensed MDs and NPs who evaluate them via telemedicine and prescribe where medically appropriate. A 503A compounding pharmacy then ships the medication directly to the patient.
You keep your brand and your patient relationship. The medical team stays responsible for all clinical decisions. You stay firmly inside your chiropractic scope of practice. For a deeper look at the compliance side, see can chiropractors prescribe peptides.
Semaglutide vs. tirzepatide: what your patients get
Semaglutide is a GLP-1 receptor agonist that regulates appetite and supports weight management — the clinically proven foundation of medical weight loss. Tirzepatide is a dual GLP-1/GIP receptor agonist and is generally considered the most powerful weight-loss option available. Both are available through the program's pharmacy network, with the licensed provider selecting what's appropriate for each patient after intake and, where indicated, lab work.
Lab work itself can be an additional revenue line you control — you decide which labs to offer and how to price them. The medications pair naturally with recovery and tissue-repair options too; see BPC-157 and tissue-repair peptides for chiropractors.
How the program works in three steps
1. You refer your patient. Send a digital intake link — onboarding takes under ten minutes, with optional lab work routed through the platform.
2. Licensed providers evaluate. Board-certified MDs and NPs review the case via telemedicine and prescribe where medically appropriate.
3. The pharmacy ships direct. A 503A compounding pharmacy sends the GLP-1 medication straight to your patient, and you earn on every fulfillment.
What a GLP-1 program can add to your revenue
Because you set your own retail pricing, your margins depend on how you package and price your programs. Partner practices commonly report adding $5,000 to $15,000+ in new monthly revenue within 60 days. For a full breakdown of the numbers and pricing models, read peptide therapy revenue for chiropractors. (Revenue references are not typical results and are not a guarantee of any specific outcome.)
The short version
You offer a name-brand-quality GLP-1 weight loss program under your own practice, set your own prices, and keep your patients — while an independent medical team and pharmacy handle everything you legally can't. Most practices are live within 24 hours.